Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455].
Details
Serval ID
serval:BIB_74C3D3CD6DB5
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455].
Journal
ESMO open
ISSN
2059-7029 (Electronic)
ISSN-L
2059-7029
Publication state
Published
Issued date
06/2022
Peer-reviewed
Oui
Volume
7
Number
3
Pages
100494
Language
english
Notes
Publication types: Published Erratum
Publication Status: ppublish
Publication Status: ppublish
Pubmed
Web of science
Open Access
Yes
Create date
04/04/2023 16:57
Last modification date
28/11/2023 8:12